First Time Loading...

Indivior PLC
LSE:INDV

Watchlist Manager
Indivior PLC Logo
Indivior PLC
LSE:INDV
Watchlist
Price: 1 432 GBX 0.35% Market Closed
Updated: May 11, 2024

Indivior PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Indivior PLC
Revenue Peer Comparison

Comparables:
GSK
AZN
VRNA
HIK
DPH

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Indivior PLC
LSE:INDV
Revenue
$1.1B
CAGR 3-Years
19%
CAGR 5-Years
3%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Revenue
£30.7B
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
2%
AstraZeneca PLC
LSE:AZN
Revenue
$47.6B
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
6%
Verona Pharma PLC
NASDAQ:VRNA
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Revenue
$2.9B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
8%
Dechra Pharmaceuticals PLC
LSE:DPH
Revenue
£761.5m
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
15%

See Also

What is Indivior PLC's Revenue?
Revenue
1.1B USD

Based on the financial report for Mar 31, 2024, Indivior PLC's Revenue amounts to 1.1B USD.

What is Indivior PLC's Revenue growth rate?
Revenue CAGR 5Y
3%

Over the last year, the Revenue growth was 19%. The average annual Revenue growth rates for Indivior PLC have been 19% over the past three years , 3% over the past five years .